430 related articles for article (PubMed ID: 33262254)
21. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
[TBL] [Abstract][Full Text] [Related]
22. Single-cell analysis reveals new evolutionary complexity in uveal melanoma.
Durante MA; Rodriguez DA; Kurtenbach S; Kuznetsov JN; Sanchez MI; Decatur CL; Snyder H; Feun LG; Livingstone AS; Harbour JW
Nat Commun; 2020 Jan; 11(1):496. PubMed ID: 31980621
[TBL] [Abstract][Full Text] [Related]
23. A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.
Fedorenko IV; Evernden B; Kenchappa RS; Sahebjam S; Ryzhova E; Puskas J; McIntosh L; Caceres G; Magliocco A; Etame A; Harbour JW; Smalley KS; Forsyth PA
Melanoma Res; 2016 Oct; 26(5):481-6. PubMed ID: 27285292
[TBL] [Abstract][Full Text] [Related]
24. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
25. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.
Lin Z; Süsskind D
J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679
[TBL] [Abstract][Full Text] [Related]
26. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
[TBL] [Abstract][Full Text] [Related]
27. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
Krishna Y; McCarthy C; Kalirai H; Coupland SE
Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma.
Das D; Kaur I; Ali MJ; Biswas NK; Das S; Kumar S; Honavar SG; Maitra A; Chakrabarti S; Majumder PP
Optom Vis Sci; 2014 Jul; 91(7):e185-92. PubMed ID: 24927141
[TBL] [Abstract][Full Text] [Related]
32. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract][Full Text] [Related]
33. Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
Dror R; Lederman M; Umezawa K; Barak V; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1811-6. PubMed ID: 19892878
[TBL] [Abstract][Full Text] [Related]
34. Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.
Koch EAT; Petzold A; Wessely A; Dippel E; Eckstein M; Gesierich A; Gutzmer R; Hassel JC; Knorr H; Kreuzberg N; Leiter U; Loquai C; Meier F; Meissner M; Mohr P; Pföhler C; Rahimi F; Schadendorf D; Schlaak M; Thoms KM; Ugurel S; Utikal J; Weichenthal M; Schuler-Thurner B; Berking C; Heppt MV
Front Med; 2023 Oct; 17(5):878-888. PubMed ID: 37432641
[TBL] [Abstract][Full Text] [Related]
35. Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma.
Kraehenbuehl L; Holland A; Armstrong E; O'Shea S; Mangarin L; Chekalil S; Johnston A; Bomalaski JS; Erinjeri JP; Barker CA; Francis JH; Wolchok JD; Merghoub T; Shoushtari AN
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681616
[TBL] [Abstract][Full Text] [Related]
36. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.
Kaštelan S; Antunica AG; Oresković LB; Pelčić G; Kasun E; Hat K
Curr Med Chem; 2020; 27(8):1350-1366. PubMed ID: 31272342
[TBL] [Abstract][Full Text] [Related]
38. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
39. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
[TBL] [Abstract][Full Text] [Related]
40. Clinical determinants of long-term survival in metastatic uveal melanoma.
Koch EAT; Petzold A; Wessely A; Dippel E; Erdmann M; Heinzerling L; Hohberger B; Knorr H; Leiter U; Meier F; Mohr P; Rahimi F; Schell B; Schlaak M; Terheyden P; Schuler-Thurner B; Ugurel S; Utikal J; Vera J; Weichenthal M; Ziller F; Berking C; Heppt MV
Cancer Immunol Immunother; 2022 Jun; 71(6):1467-1477. PubMed ID: 34709438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
